Bonjesta

Bonjesta combines doxylamine hydrogen succinate and pyridoxine hydrochloride for oral use. It is commonly used to manage nausea and vomiting during pregnancy. This medication is manufactured by Exeltis Poland Sp. Z O.O. and is available in the EU market.

Bonjesta is primarily used to alleviate nausea and vomiting associated with pregnancy. The combination of doxylamine and pyridoxine works to provide relief from these symptoms. Many individuals seek Bonjesta as a solution for morning sickness and related discomforts during pregnancy.

Bonjesta may cause drowsiness, dizziness, or dry mouth in some users. These effects are generally mild and temporary. It is important to monitor how your body responds to the medication and consult a healthcare provider if any adverse effects persist or worsen.

Bonjesta should be used with caution, especially if you have a history of allergies to its ingredients. It is advisable to avoid alcohol and certain medications that may interact with Bonjesta. Always follow the guidance of a healthcare professional when using this medication.

Bonjesta may interact with alcohol, sedatives, and other medications that cause drowsiness. It is important to inform your healthcare provider about all the medications you are taking to avoid potential interactions. Always consult a healthcare professional before starting or stopping any medication.